Click here for more details.HRA Pharma has set up LYSOSAFE, a service associated with the use of Lysodren and available to all European hospitals using the European approved Lysodren (mitotane, 500 mg tablets). The aim of this service is to support prescribers in optimizing the safety and efficacy of treatment with Lysodren by monitoring patients' plasma mitotane levels.
LYSOSAFE is a completely free service, which includes shipping the samples to a unique centralized bioanalytical centre, testing the samples following standard protocols and returning the results within a few days
Click here for more details.